Jagsonpal Pharmaceuticals quarterly resultsNext results date, and the last two years

Next results · July–September 2026
Wednesday, 28 October 2026
In 5 days

The board meets to approve the quarter's results. Jagsonpal Pharmaceuticals told NSE on Wednesday, 21 October.

Get an email before Jagsonpal Pharmaceuticals reports

Up to three days before, and on the day with the results as soon as they're filed.

Not investment advice

Dates come from Jagsonpal Pharmaceuticals's filings on NSE and can change until the meeting happens. This is information, not a recommendation to buy or sell. Stockport is not a SEBI-registered investment adviser.

Source: NSE · updated 23 Oct, 09:05 IST

Over the last 8 quarters on file, Jagsonpal Pharmaceuticals published its results 21 to 36 days after each quarter ended. Its July–September results came on 3 November 2025 and 23 October 2024.

Past results dates

NSE JAGSNPHARM
QuarterPeriodResults filedDays after quarter endResults
Q2 FY27Jul–Sep 2026Wed 28 Oct 2026Upcoming28
Q1 FY27Apr–Jun 2026Wed 29 Jul 202629Read
Q4 FY26Jan–Mar 2026Mon 27 Apr 202627Read
Q3 FY26Oct–Dec 2025Wed 21 Jan 202621Read
Q2 FY26Jul–Sep 2025Mon 3 Nov 202534Read
Q1 FY26Apr–Jun 2025Sat 26 Jul 202526Read
Q4 FY25Jan–Mar 2025Tue 6 May 202536Read
Q3 FY25Oct–Dec 2024Wed 22 Jan 202522Read
Q2 FY25Jul–Sep 2024Wed 23 Oct 202423Read

Never miss a results day on your stocks

Stockport is an investment research journal for serious investors. It makes your thesis actionable by reading out claims from your raw notes and keeping score against them.

Try Stockport free
Read before results day

Questions about Jagsonpal Pharmaceuticals's results

When will Jagsonpal Pharmaceuticals announce its July–September 2026 results?

On Wednesday, 28 October 2026, at its board meeting, according to the company's filing with NSE on 21 October.

Where can I read Jagsonpal Pharmaceuticals's results?

Once the company files them with NSE, a link appears on this page next to the quarter. The last eight quarters' filings are linked in the table above.